Mattern Wealth Management LLC Has $1.56 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Mattern Wealth Management LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 61.1% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 2,664 shares of the healthcare conglomerate’s stock after selling 4,179 shares during the period. Mattern Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,558,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group in the 3rd quarter worth $27,000. Macroview Investment Management LLC grew its position in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares during the period. Delos Wealth Advisors LLC lifted its holdings in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC purchased a new stake in UnitedHealth Group during the second quarter valued at $31,000. Finally, Global Wealth Strategies & Associates increased its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. TD Cowen upped their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday. Robert W. Baird increased their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Bank of America dropped their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Morgan Stanley reduced their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Finally, HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Three research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $615.58.

UnitedHealth Group Trading Down 0.2 %

UNH traded down $1.37 on Tuesday, reaching $570.10. 891,265 shares of the company traded hands, compared to its average volume of 3,946,539. The firm has a fifty day simple moving average of $584.55 and a two-hundred day simple moving average of $535.49. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The company has a market cap of $526.44 billion, a P/E ratio of 37.23, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business posted $6.56 EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.